MedPath
Found 29 clinical trials|View Analysis
Sort by:

Multicenter Registration Study on Allergic Bronchopulmonary Aspergillosis

Not yet recruiting
Conditions
Allergic Bronchopulmonary Aspergillosis
First Posted Date
2024-10-16
Last Posted Date
2024-10-16
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
300
Registration Number
NCT06645210
Locations
🇨🇳

Peking University Third Hospital, Beijing, Beijing, China

iMagIng pulmonaRy Aspergillosis Using Gallium-68-dEferoxamine

Phase 2
Not yet recruiting
Conditions
Pulmonary Aspergillosis
Chronic Pulmonary Aspergillosis
Allergic Bronchopulmonary Aspergillosis
First Posted Date
2024-02-06
Last Posted Date
2024-04-16
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
10
Registration Number
NCT06244979

A Randomized Trial of Prednisolone, Itraconazole, or Their Combination in Allergic Bronchopulmonary Aspergillosis

Phase 3
Recruiting
Conditions
Allergic Bronchopulmonary Aspergillosis
Interventions
First Posted Date
2023-12-18
Last Posted Date
2024-04-17
Lead Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Target Recruit Count
300
Registration Number
NCT06174922
Locations
🇮🇳

Chest Clinic, Dept. of Pulmonary Medicine, Chandigarh, India

Allergic Bronchopulmonary Aspergillosis Prescreening Study

Withdrawn
Conditions
Asthma
Allergic Bronchopulmonary Aspergillosis
ABPA
First Posted Date
2023-06-15
Last Posted Date
2024-01-16
Lead Sponsor
Community Pharmacology Services Ltd
Registration Number
NCT05903612
Locations
🇬🇧

CPS Research, Glasgow, United Kingdom

Voriconazole Inhalation Powder for the Treatment of Pulmonary Aspergillosis

Conditions
Invasive Pulmonary Aspergillosis
Allergic Bronchopulmonary Aspergillosis
Chronic Pulmonary Aspergillosis
Aspergillus Tracheobronchitis
Anastomotic Infection
Pulmonary Fungal Infection
First Posted Date
2023-06-09
Last Posted Date
2024-11-21
Lead Sponsor
TFF Pharmaceuticals, Inc.
Registration Number
NCT05897294

Modeling Bronchial Epithelium in Severe Asthma With Human Induced Pluripotent Stem Cells (iPSC)

Not Applicable
Completed
Conditions
Allergic Bronchopulmonary Aspergillosis (ABPA)
Severe Asthma
Interventions
Other: Blood sample
First Posted Date
2022-11-15
Last Posted Date
2023-08-29
Lead Sponsor
University Hospital, Montpellier
Target Recruit Count
4
Registration Number
NCT05616338
Locations
🇫🇷

university Hospital of Montpellier, Montpellier, France

Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome

Not Applicable
Recruiting
Conditions
Chronic Pulmonary Aspergillosis
Allergic Bronchopulmonary Aspergillosis
Interventions
First Posted Date
2022-07-06
Last Posted Date
2024-02-14
Lead Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Target Recruit Count
104
Registration Number
NCT05444946
Locations
🇮🇳

Chest clinic, PGIMER, Chandigarh, India

🇮🇳

Chest clinic, Chandigarh, India

A Prospective Study on Optimizing Treatment for ABPA

Not Applicable
Conditions
Allergic Bronchopulmonary Aspergillosis
Interventions
First Posted Date
2021-11-22
Last Posted Date
2021-11-22
Lead Sponsor
Shanghai Zhongshan Hospital
Target Recruit Count
100
Registration Number
NCT05129033

Physiotherapy Treatment Plan in Allergic Bronchopulmonary Aspergillosis: Case Report

Completed
Conditions
Obstructive Pulmonary Disease
First Posted Date
2021-02-10
Last Posted Date
2021-02-10
Lead Sponsor
Universidad Católica de Ávila
Target Recruit Count
1
Registration Number
NCT04748900
Locations
🇪🇸

Universidad Católica de Ávila, Ávila, Spain

Immune Profiles in CF Fungal Infection

Completed
Conditions
Allergic Bronchopulmonary Aspergillosis
Fungal Infection
Cystic Fibrosis
First Posted Date
2020-07-20
Last Posted Date
2024-07-18
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
24
Registration Number
NCT04476758
Locations
🇺🇸

Childrens Hospital Colorado, Highlands Ranch, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath